Table 3.
B | S.E | Wals | P-value | OR | 95% CI | |||
---|---|---|---|---|---|---|---|---|
Model 1 | Q1 | 323.55 | < 0.001 | 1 | ||||
Q2 | 0.68 | 0.16 | 18.94 | < 0.001 | 1.98 | 1.45 | 2.68 | |
Q3 | 1.31 | 0.13 | 94.97 | < 0.001 | 3.70 | 2.84 | 4.80 | |
Q4 | 2.01 | 0.13 | 235.99 | < 0.001 | 7.45 | 5.76 | 9.62 | |
Model 2 | Q1 | 241.06 | < 0.001 | 1 | ||||
Q2 | 0.59 | 0.16 | 13.89 | < 0.001 | 1.80 | 1.32 | 2.46 | |
Q3 | 1.13 | 0.14 | 69.63 | < 0.001 | 3.11 | 2.38 | 4.05 | |
Q4 | 1.77 | 0.13 | 177.008 | < 0.001 | 5.85 | 4.51 | 7.59 | |
Model 3 | Q1 | 162.973 | < 0.001 | 1 | ||||
Q2 | 0.54 | 0.16 | 11.171 | < 0.001 | 1.72 | 1.25 | 2.36 | |
Q3 | 1.01 | 0.14 | 51.213 | < 0.001 | 2.74 | 2.08 | 3.60 | |
Q4 | 1.57 | 0.14 | 124.508 | < 0.001 | 4.80 | 3.64 | 6.32 |
Model 1: Not adjusted
Model 2: Adjusted for sex, age, smoking, drinking, and physical activity
Model 3: Adjusted for sex, age, smoking, drinking, physical activity, Cr, diabetes, hyperlipidemia, and hypertension
Cr creatinine